Prostaglandin E2 signalling pathway in human T lymphocytes from healthy and conjunctiva basal cell carcinoma-bearing subjects

Immunology and Cell Biology

Volumn 79, Issue 5, 2001, Pages 482-489

  Venza, I ^a   Giordano, L ^a   Piraino, G ^a   Medici, N ^a   Ceci, G ^a   Teti, D ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Conjunctival neoplasms; Cyclic AMP responsive element binding protein; Prostaglandin; T lymphocytes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOTRANSFERASE INHIBITOR; PROSTAGLANDIN E2; PROTEIN KINASE C INHIBITOR; STAUROSPORINE;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UVEA MELANOMA; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 2; ADULT; CARCINOMA, BASAL CELL; CONJUNCTIVAL NEOPLASMS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DINOPROSTONE; GENES, REPORTER; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; PHOSPHORYLATION; PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0035572254     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2001.01034.x     Document Type: Article

References (51)

1. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
2. Effect of prostaglandin E2 on pokeweed mitogen-activated human lymphocyte cultures
3. Prostaglandin E2-induced inhibition of the in vitro immune response by SRBC-stimulated human lymphocytes
4. A short incubation with PGE2 affects the proliferative response of T lymphocytes to PWM
5. Prostaglandin E2 induction of binding activity to CRE and AP-2 elements in human T lymphocytes
6. Polyamine metabolism in prostaglandin E2-treated human T lymphocytes
7. Transcription from a murine T-cell receptor V beta promoter depends on a conserved decamer motif similar to the cyclic AMP response element
8. Functional importance of the cyclic AMP response element-like decamer motif in the CD8 alpha promoter
9. CD3 delta enhancer: CREB interferes with the function of a murine CD3-delta A binding factor (M delta AF)
10. Transcriptional regulation of T cell receptor genes
11. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB
12. Identification of a novel, spliced variant of CREB that is preferentially expressed in the thymus
13. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice
14. Severe impairment of spermatogenesis in mice lacking the CREM gene
15. The antiapoptotic gene mcl-1 is upregulated by the phos-phatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB
16. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF (betaTrCP) ubiquitin ligase
17. Prostaglandin E2 increases proenkephalin mRNA level in rat astrocyte-enriched culture
18. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
19. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation
20. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase
21. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB
22. Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein
23. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: A molecular mechanism of Tax transactivation
24. T cell activation signals upregulate cbp-dependent transcriptional activity
25. CREB-mediated transcriptional control
26. Nuclear protein CBP is a coactivator for the transcription factor CREB
27. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
28. Expression of cyclo-oxygenase-1 and -2 in human colorectal cancer
29. Expression of cyclooxygenase-2 in human lung carcinoma
30. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
31. Expression of cyclooxygenase-2 in human gastric carcinoma
32. Cyclooxygenase-2 expression is upregulated in human pancreatic cancer
33. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
34. Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck
35. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Upregulation of interleukin 10 and downregulation of interleukin 12 production
36. Resistance to PGE2 inhibition of PWM-stimulated lymphocytes from neoplastic patients
37. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription
38. An in vitro transcription analysis of early responses of the human immuno-deficiency virus type 1 long terminal repeat to different transcriptional activators
39. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
40. Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p-60
41. Staurosporine, a potent inhibitor of phospholipid/Ca++-dependent protein kinase
42. Immunology of ocular tumours
43. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist
44. CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter
45. Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4)
46. Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein
47. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: A possible mechanism to polarize Th2 type response in BALB/c mice
48. Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: The role of p38 mitogen-activated protein kinase
49. CBP-independent activation of CREM and CREB by the LIM-only protein ACT
50. Analysis of an activator: Coactivator complex reveals an essential role for secondary structure in transcriptional activation